UPDATED: Clinician FAQS and guidance on COVID-19 vaccine

The Clinician FAQS and guidance on COVID-19 vaccine for patient receiving SACT. Version 6.0. Updated 21st December 2021 is now available on the UKCB website here: https://www.ukchemotherapyboard.org/publications. 

This updated guidance version 6 changes:
•    FAQ 1 Clarification for hormonal agents
•    FAQ 8 updated to reflect reinforcing (booster) dose after 3 primary doses.
•    FAQ13a: Updated figure
•    FAQ 13 FAQ 13b Updated to reflect change in recommendation about optimal timing.
•    New FAQ 14 added to reflect need for a reinforcing (booster) dose after 3rd primary dose

Please share with your colleagues.

Have a Merry Christmas and Happy New Year

Netty Cracknell and Pinkie Chambers
Co-chairs of the UK Chemotherapy Board

Latest News

By BOPA Research Subcommittee on 25th May 2026

4-Week Reminder: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN   4 Weeks left to submit your Abstract for the 29th Annual BOPA Conference 2026. Submit your work…

Read article
By BOPA E&T Subcommittee on 20th May 2026

SAVE THE DATE: BOPA Introduction to Cancer Course, London, September 2026

The popular Introduction to Cancer Course is coming to London in September 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 17th & Friday 18th September 2026 WHERE: University College Hospital,…

Read article
By BOPA Executive Committee on 19th May 2026

Invitation to share views on polypharmacy during cancer care – patient and healthcare professional surveys (Macmillan Cancer Support and the Royal College of Pharmacy)

Dear colleagues, Macmillan Cancer Support and the Royal College of Pharmacy are inviting patients and healthcare professionals to complete a short anonymous survey about experiences of taking and managing medicines…

Read article
By BOPA Committee on 15th May 2026

BOPA will no longer be using X (formerly Twitter) as a social media platform

BOPA will no longer be using X (formerly Twitter) as a social media platform. You can continue to keep up to date with all BOPA news, updates, webinars, etc and…

Read article